Concepedia

Marlene Langenbach

ML

5

Publications

139

Citations

5

H-Index

2022

Active since

Affiliations

University of Freiburg(Current)

University Medical Center Freiburg

German Cancer Research Center

University of Zurich

Deutschen Konsortium für Translationale Krebsforschung

Marlene Langenbach is an author at University of Freiburg specializing in tumor microenvironment, neuroinflammation, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2022–2024

5

Publications

5

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

Jenny N. H. G. Ho, Dominik Schmidt, Theresa Lowinus et al. · Blood · 2022 · 51 citations · Full text

Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease

Marie Czech, Sophia Schneider, Nina Peltokangas et al. · Science Translational Medicine · 2024 · 28 citations

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production

Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld et al. · Molecular Cancer Research · 2023 · 25 citations · Full text

Anti–PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation

Janaki Manoja Vinnakota, Rachael C. Adams, Dimitrios Athanassopoulos et al. · Science Translational Medicine · 2024 · 22 citations

, , +18

Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells

Zhen Zhang, Marlene Langenbach, Sagar Sagar et al. · Nature Immunology · 2024 · 13 citations · Full text

Rows per page

1–5 of 5